New Daily Pill Delivers 12% Weight Loss — No Needle Required

An experimental oral drug called aleniglipron has produced weight loss of up to 12.1% of body weight over 36 weeks in trial participants, a result that puts it in the same range as some injectable GLP-1 treatments.

That distinction matters. Unlike Wegovy and Ozempic, which require injections, aleniglipron is a small molecule taken once a day, with or without food. That alone could make it more appealing to patients who avoid needles, and a pill is generally cheaper and easier to manufacture at scale than an injectable.

If the drug clears further trials, its main impact may not be medical at all — it could be about access. A cheaper, easier-to-produce option widens who can actually afford obesity treatment, not just who responds to it.

Source: sciencedaily.com